Obesity starts in the brainRecent study links insulin sensitivity in the brain to obesity, suggesting diet's direct impact on brain function and health.Obesity, recognized as a disease, poses challenges for healthcare systems globally.
Dermatologists find ultraviolet irradiation increases appetite but prevents body weight gainUV exposure affects norepinephrine, leptin levels, and subcutaneous fat, potentially influencing energy expenditure and offering new obesity treatment approaches.
Obesity starts in the brainRecent study links insulin sensitivity in the brain to obesity, suggesting diet's direct impact on brain function and health.Obesity, recognized as a disease, poses challenges for healthcare systems globally.
Dermatologists find ultraviolet irradiation increases appetite but prevents body weight gainUV exposure affects norepinephrine, leptin levels, and subcutaneous fat, potentially influencing energy expenditure and offering new obesity treatment approaches.
Overactive cells linked to type 2 diabetesOxygen treatment reduced cell activity but did not improve metabolic function in type 2 diabetes patients.
How rival weight-loss drugs fare at treating obesity, diabetes and moreUnderstanding the differences between obesity drugs can lead to personalized treatment strategies.New research shows varying effectiveness among drugs like semaglutide and tirzepatide in metabolic improvements.
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia - NaturePropionic acidemia is a rare disorder with potentially life-threatening metabolic decompensation events.mRNA-3927 therapy showed promising results in reducing the risk of metabolic decompensation events in participants.